Clinical Trial

Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to examine the feasibility, acceptability, and preliminary efficacy of a digital intervention for co-occurring cannabis use and depression. Participants will be randomized to complete Amplification of Positivity - Cannabis Use (AMP-C) or symptom tracking. The main outcomes will include changes in depressive symptoms and cannabis use, as well as usability ratings.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2028-01 -> 2028-01-31 2026-06-03
minor Completion pushed: 2029-01 -> 2029-06-29 2026-06-03
Trial Details
NCT Number NCT06878859
Lead Sponsor Massachusetts General Hospital
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Depression - Major Depressive Disorder, Cannabis Use Disorder, Mental Disorder
Enrollment 80 participants
Start Date 2026-02-23
Primary Completion 2028-01-31 (estimated)
Study Completion 2029-06-29 (estimated)
Updated on ClinicalTrials.gov 2026-06-02